| Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients R Najjar-Debbiny, N Gronich, G Weber, J Khoury, M Amar, N Stein, ... Clinical Infectious Diseases 76 (3), e342-e349, 2023 | 494 | 2023 |
| BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel T Brosh-Nissimov, E Orenbuch-Harroch, M Chowers, M Elbaz, L Nesher, ... Clinical Microbiology and Infection 27 (11), 1652-1657, 2021 | 346 | 2021 |
| COVID-19 vaccine–Long term immune decline and breakthrough infections J Khoury, R Najjar-Debbiny, A Hanna, A Jabbour, YA Ahmad, A Saffuri, ... Vaccine 39 (48), 6984-6989, 2021 | 115 | 2021 |
| Effectiveness of molnupiravir in high-risk patients: a propensity score matched analysis R Najjar-Debbiny, N Gronich, G Weber, J Khoury, M Amar, N Stein, ... Clinical infectious diseases 76 (3), 453-460, 2023 | 55 | 2023 |
| Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study R Shibli, O Barnett, Z Abu-Full, N Gronich, R Najjar-Debbiny, I Doweck, ... The Lancet Regional Health–Europe 11, 2021 | 51 | 2021 |
| Association between the BNT162b2 messenger RNA COVID-19 vaccine and the risk of sudden sensorineural hearing loss Y Yanir, I Doweck, R Shibli, R Najjar-Debbiny, W Saliba JAMA Otolaryngology–Head & Neck Surgery 148 (4), 299-306, 2022 | 41 | 2022 |
| Effectiveness of Evusheld in immunocompromised patients: propensity score–matched analysis R Najjar-Debbiny, N Gronich, G Weber, N Stein, W Saliba Clinical Infectious Diseases 76 (6), 1067-1073, 2023 | 40 | 2023 |
| Sudden sensorineural hearing loss during the COVID-19 pandemic I Doweck, Y Yanir, R Najjar-Debbiny, R Shibli, W Saliba JAMA Otolaryngology–Head & Neck Surgery 148 (4), 373-375, 2022 | 31 | 2022 |
| Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2 T Hertz, S Levy, D Ostrovsky, H Oppenheimer, S Zismanov, A Kuzmina, ... Nature Communications 14 (1), 4575, 2023 | 17 | 2023 |
| The effect of intra-articular injection of Diprospan at the knee joint on the hypothalamic-pituitary-adrenal axis G Habib, R Zahran, R Najjar, S Badarny, A Jabbour, S Artul, G Hakim, ... Swiss Medical Weekly 145 (2122), w14134-w14134, 2015 | 13 | 2015 |
| Association between Guillain-Barré syndrome and COVID-19 infection and vaccination: a population-based nested case-control study H Bishara, A Arbel, O Barnett-Griness, S Bloch, S Cohen, ... Neurology 101 (20), e2035-e2042, 2023 | 12 | 2023 |
| Healthcare-associated infection prevention and control practices in Israel: results of a national survey R Najjar-Debbiny, B Chazan, R Lobl, MT Greene, D Ratz, S Saint, ... BMC Infectious Diseases 22 (1), 739, 2022 | 10 | 2022 |
| Analysis of four carbapenem-resistant Acinetobacter baumannii outbreaks using Fourier-transform infrared spectroscopy H Kon, E Temkin, P Elmalih, A Keren-Paz, D Ben-David, ... Infection Control & Hospital Epidemiology 44 (6), 991-993, 2023 | 7 | 2023 |
| Correlates of protection for booster doses of the BNT162b2 vaccine T Hertz, S Levy, D Ostrovsky, H Oppenheimer, S Zismanov, A Kuzmina, ... medRxiv, 2022.07. 16.22277626, 2022 | 7 | 2022 |
| Hospitalised patients with breakthrough COVID-19 following vaccination during two distinct waves in Israel, January to August 2021: a multicentre comparative cohort study T Brosh-Nissimov, Y Maor, M Elbaz, S Lipman-Arens, Y Wiener-Well, ... Eurosurveillance 27 (20), 2101026, 2022 | 7 | 2022 |
| Association between COVID-19 infection and pulmonary fibrosis: A nested case-control study R Najjar-Debbiny, O Barnett-Griness, J Khoury, N Gronich, G Weber, ... The American Journal of Medicine 136 (11), 1087-1093. e2, 2023 | 5 | 2023 |
| Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study R Najjar-Debbiny, A Bazazhina, N Schwartz, P Shaked, W Saliba, ... Infection 50 (4), 973-980, 2022 | 5 | 2022 |
| Perceptions of organizational culture among infection preventionists in Israel, the United States, and Thailand: Results from national infection prevention surveys MT Greene, MA Borg, MJ Schwaber, R Najjar-Debbiny, ... American Journal of Infection Control 52 (2), 246-248, 2024 | 4 | 2024 |
| Immunity waning after COVID vaccine booster vs. infection—better than expected J Khoury, R Najjar-Debbiny, A Elemy, A Jabbour, J Haj, M Abu-Sini, ... Infectious Diseases 54 (11), 828-831, 2022 | 4 | 2022 |
| Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study A Arbel, H Bishara, O Barnett‐Griness, S Cohen, R Najjar‐Debbiny, ... European Journal of Neurology 30 (12), 3868-3876, 2023 | 3 | 2023 |
